South Korea and Japan are home to Asia’s largest comprehensive universal health insurance systems - making them attractive markets for Swedish companies with medical devices, pharmaceuticals, and other healthcare products.
The healthcare systems in both countries share many common features, including universal coverage, high healthcare expenditures, and a strong emphasis on preventative care. Both countries have advanced medical technology and large pharmaceutical and medical device markets.
Join our webinar for the latest insights on:
- The healthcare systems in Japan and South Korea
- Market overview with focus on med-tech and digital health
- Market entry strategies
About the markets
Compulsory public health insurance systems form the basis of both South Korea's and Japan’s sophisticated healthcare systems, that serve a combined population of 175 million people. This has created a largely reimbursed market for medical devices and medicine.
Japan’s medical expenditures have increased over 30% since 2000 and now constitute 11% of GDP and are expected to continue growing as the populations ages.
South Korea’s health expenditures are 8.8% of GDP and forecasted to grow at a CAGR of 6.2% during 2020-2025, primarily driven by an aging population and adoption of new technologies.
Agenda
Introduction - Anna Riby, Swecare and Britta Stenson, Business Sweden
South Korea presentation - Bongsoon Park, Business Sweden in Seoul
Japan presentation - Magnus Blondell, Business Sweden in Tokyo
Both Ms Park and Mr Blondell have over 20 years' experience supporting Swedish healthcare companies develop and implement market entry strategies in markets across Asia.
During the seminar, they will share their market knowledge, present different market entry strategies, and host an open Q&A session.
Welcome to join us!
Swecare and Business Sweden